Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada.
Faculty of Medicine, University of British Columbia, Vancouver, Canada.
Syst Rev. 2019 Jan 24;8(1):32. doi: 10.1186/s13643-019-0947-2.
Emergence coughing and bucking, secondary to endotracheal tube stimulation of the tracheal mucosa, frequently occurs after the general anesthetic recedes. Besides general unpleasantness, coughing has important physiological sequelae that may be detrimental to the postoperative patient. Multiple pharmacological strategies have been published, but prior systematic reviews on this topic have neither been comprehensive enough in their literature or medication search, nor provided us the answer regarding what the best pharmacological method is to prevent or minimize peri-extubation coughing. Our systematic review and network meta-analysis' primary objective is to determine the relative efficacies of different pharmacological methods on decreasing coughing (none to mild compared to moderate to severe, as defined by the modified Minogue scale) during emergence after a general anesthetic with endotracheal intubation in adult elective surgeries. Medications of interest are lidocaine or lignocaine (intravenous (IV), intracuff alkalinized, intracuff non-alkalinized, topical, endotracheal application), dexmedetomidine IV, remifentanil IV, and fentanyl IV. These medications were selected based on a preliminary review of the literature.
Using a predefined search strategy, we will search MEDLINE, Cochrane Central Register of Controlled Trials, Embase, Cochrane Database of Systematic Reviews, ACP Journal Club, Database of Abstracts of Reviews of Effects, and the Cochrane Methodology Register, with no date or language restrictions. Gray literature search will encompass conference abstracts, Web of Science, and references from publications selected for full-text review. Two reviewers will independently screen the retrieved literature using predetermined inclusion criteria, process publications selected for full-text review, extract data from publications chosen for study inclusion, and evaluate for bias using the Cochrane risk of bias assessment. Risk ratios and 95% confidence intervals will be calculated for each study, and a surface under the cumulative ranking curve will determine the relative rank of each intervention in its ability to prevent coughing on emergence.
The proposed systematic review and network meta-analysis will not only provide a more thorough review of common medications used to decrease emergence coughing, but also inform clinicians which of these pharmacological strategies is the best approach.
PROSPERO CRD42018102870.
全身麻醉消退后,由于气管内导管刺激气管黏膜,常出现呛咳和抽搐。除了一般的不适外,咳嗽还会产生重要的生理后果,可能对术后患者不利。已经发表了多种药理学策略,但之前关于这个主题的系统评价在文献或药物搜索方面不够全面,也没有为我们提供预防或尽量减少拔管期呛咳的最佳药理学方法是什么的答案。我们的系统评价和网络荟萃分析的主要目的是确定不同药理学方法在减少全身麻醉后气管内插管的成人择期手术中苏醒时咳嗽(根据改良 Minogue 量表定义为无至轻度与中至重度相比)的相对疗效。感兴趣的药物是利多卡因或丁卡因(静脉内(IV)、气管内套囊内碱性化、气管内套囊内非碱性化、局部、气管内应用)、右美托咪定 IV、瑞芬太尼 IV 和芬太尼 IV。这些药物是根据文献的初步回顾选择的。
使用预定义的搜索策略,我们将搜索 MEDLINE、Cochrane 对照试验中心注册库、Embase、Cochrane 系统评价数据库、ACP 期刊俱乐部、效应摘要数据库和 Cochrane 方法学登记处,不限制日期或语言。灰色文献搜索将包括会议摘要、Web of Science 和为全文审查选择的出版物的参考文献。两名审查员将独立使用预定的纳入标准筛选检索到的文献,处理为全文审查选择的出版物,从选择纳入研究的出版物中提取数据,并使用 Cochrane 偏倚风险评估评估偏倚。将为每项研究计算风险比和 95%置信区间,并通过累积排名曲线下面积确定每种干预措施预防苏醒时咳嗽的相对排名。
拟议的系统评价和网络荟萃分析不仅将对用于减少苏醒期咳嗽的常用药物进行更全面的综述,还将为临床医生提供这些药理学策略中哪一种是最佳方法的信息。
PROSPERO CRD42018102870。